The Estée Lauder Companies Inc. (ELCI34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 24.22 |
|---|---|
| 52-week range | 14.50 – 28.35 |
| Return, 1 month / 3 months | +15.0% / +39.5% |
| Return, 1 year / 3 years | +8.8% / −3.2% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 53.7% |
| Worst drawdown (1 year) | -43.6% |
| Average daily value traded | 0.01M BRL |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Estée Lauder Companies is a beauty company that makes and markets skincare, makeup, fragrance and hair care products under a family of brands, including names such as Clinique, MAC Cosmetics and La Mer. Its customers are everyday consumers who shop through department stores, specialty beauty retailers, travel retail outlets and online channels. The company is based in New York in the United States and sells its products in markets around the world.
The Estée Lauder Companies Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code ELCI34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Estée Lauder Companies Inc. (ELCI34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 24.22 on 27 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 627 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.8% and over the last three months it rose 39.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.4% | ||
| From 52-week high | -7.9% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 39.5% | ||
| 6-month return | 52.9% | ||
| 12-month return, skipping the last month | -5.4% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.6% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M BRL | ||
| Zero-volume days | 25.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +8.2% |
|---|---|
| 1 month | +15.0% |
| 3 months | +39.5% |
| 6 months | +52.9% |
| 1 year | +8.8% |
| 3 years | −3.2% |
| 5 years | −63.7% |
Signals
| 50-day / 200-day average | 20.98 / 19.62 |
|---|---|
| Golden / death cross (60 days) | Golden, 17 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.56 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 May 2026 | USD 0.0501 |
| 25 Feb 2026 | USD 0.0513 |
| 26 Nov 2025 | USD 0.0538 |
| 29 Aug 2025 | USD 0.0523 |
| 28 May 2025 | USD 0.0540 |
| 26 Feb 2025 | USD 0.0561 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.